Pharmaceutical News and Articles

Monthly News Roundup - March 2025

FDA Approves Tremfya for Adults Patients with Active Crohn s Disease In March, Johnson Johnson announced the U.S. Food and Drug Administration (FDA) approval of

FDA Issues Complete Response Letter for Etripamil for PSVT

FDA Approves Qfitlia (fitusiran) to Treat Hemophilia A or B With or Without Inhibitors

Citrus Oil Formula May Relieve Dry Mouth for Cancer Patients

the target site, she added. This inventive and highly impactful limonene-lipid formulation could provide a simple, effective oral solution for dry mouth, offeri

FDA Approves Conexxence (denosumab-bnht), a Biosimilar to Prolia

Merck’s Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) Keytruda® (pembrolizumab) in Pivotal 3475A-D77 Trial

Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced the first data presentation from the pivotal 3475A-D77 Phase 3 trial, ev

FDA Approves Imfinzi (durvalumab) for Muscle Invasive Bladder Cancer

Utah Becomes First State to Ban Community Water Fluoridation

communities that often have the least access to dental care and to other sources of fluoride, Tomar said. Fluoride bans, he added, are misguided on a number of

FDA Approves Novartis Radioligand Therapy Pluvicto for Earlier Use Before Chemotherapy in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Trump Administration To Cut 10,000 Health and Human Services Jobs

The Trump administration will lay off 10,000 workers at the U.S. Department of Health and Human Services (HHS) as part of a major reorganization, officials anno